DULUTH, Ga., Feb. 5, 2018 /PRNewswire/ -- Merial, a global leader in animal health, today completes a major addition to its canine vaccine portfolio with the launch of RECOMBITEK Oral Bordetella ...

In recognition of World Rabies Day on September 28, the donation is for use on tribal lands and underserved communities in collaboration with Greater Good Charities DULUTH, Ga., Sept. 28, 2022 ...

Boehringer Ingelheim, a global leader in animal health, has begun its launch of Eurican L4, delivering an important new vaccine to protect dogs against the growing threat of leptospirosis, a severe ...

Boehringer Ingelheim's $885 million pet vaccines portfolio sale will bring the company closer to the $12.76 billion acquisition of Merial, an animal health company based in France.

Eli Lilly & Co. is buying Boehringer Ingelheim Vetmedica Inc.’s U.S. pet vaccines portfolio for $885 million as it continues to grow its animal unit.

Eli Lilly and Company’s LLY animal health subsidiary Elanco, announced that it has closed the previously stated acquisition of German drugmaker Boehringer Ingelheim’s Vetmedica U.S. pet ...

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San ...

Eli Lilly and Company 's LLY animal health subsidiary Elanco, announced that it has closed the previously stated acquisition of German drugmaker Boehringer Ingelheim's Vetmedica U.S. pet vaccines ...

Eli Lilly and Company LLY announced that its Elanco animal health business has agreed to acquire the U.S. pet vaccines unit – Vetmedica – and a Fort Dodge, IA-based manufacturing site from ...

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San ...